Patrick J. Mahaffy

facebook_page
twitter_page

Last quote by Patrick J. Mahaffy

The acceptance of the rucaparib [new drug application] submission represents an important milestone for rucaparib, and for Clovis. There is tremendous need for additional therapeutic options for patients with advanced mutant BRCA ovarian cancer, and we look forward to cooperating with FDA on the rucaparib NDA review.
Aug 23 2016
Find all of Patrick J. Mahaffy’s quotes that have been published in 1 different article on this page. Patrick J. Mahaffy’s quotes are organized by date and topic, making it easy for you to compare, for example, what Patrick J. Mahaffy has said both recently, and in the past, on a variety of topics. Some of the topics Patrick J. Mahaffy likes to comment on include FDA and rucaparib. Most recently, Patrick J. Mahaffy said, “The acceptance of the rucaparib [new drug application] submission represents an important milestone for rucaparib, and for Clovis. There is tremendous need for additional therapeutic options for patients with advanced mutant BRCA ovarian cancer, and we look forward to cooperating with FDA on the rucaparib NDA review.”.
Automatically powered byStoryzy
facebook_page
twitter_page
This webpage has been created by a robot: errors and absent quotes cannot be totally avoided